Dohner H, Spath D, Saadati M, Fiedler W, et al. Phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia. Blood 2026 Jan 5:blood.2025030722. doi: 10.1182/blood.2025030722.
PMID: 41490515